NOTICE OF CORRECTION - NINDS CLINICAL TRIAL PLANNING GRANT (PAR-03-051) RELEASE DATE: March 12, 2004 NOTICE: NOT-NS-04-010 National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov/) PURPOSE OF THIS NOTICE: This notice is intended to clarify the Clinical Trial Planning Grant Program announcement by the National Institute of Neurological Disorders and Stroke (NINDS) http://grants.nih.gov/grants/guide/pa-files/PAR-03-051.html. PAR-03-051 indicates that the R21 grant mechanism will be used. Subsequent to the publication of this PAR, NIH has established a new grant mechanism, the Clinical Trial Planning Grant. Therefore, starting with the April 15, 2004 receipt date, NINDS will use the NIH Clinical Trial Planning Grant (R34) award mechanism for PAR-03-151 and will provide up to $150,000 in direct costs for a single year. The award cannot be renewed. Applicants should refer to the NIH Clinical Trial Planning Grant Program for special requirements and review criteria for a planning grant application http://grants.nih.gov/grants/guide/pa-files/PA-04-008.html. INQUIRIES: Any further questions regarding these guidelines should be addressed to: Scott Janis, Ph.D. National Institute of Neurological Disorders & Stroke National Institutes of Health 6001 Executive Boulevard, Rm. 2209, MSC 9525 Bethesda, MD 20892-9525 (301) 496-9135 (301) 480-1080 Fax electronic mail: sj151t@nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files. |